Our finding that early stage tumors expressed MET markers is consistent with the role of MET in tumor expansion, where EMT can promote cancer stem cell properties, tumor invasion, and resistance to chemotherapy, and MET results in increased cell proliferation and promote metastases [54, 55]. The gene discussed is MET; the disease is cancer.